Scientific News

The role of gut microbiota and mycobiota in pre-eclampsia

Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.

The cloudy link between gut microbes and obesity

Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.

Study characterizes the microbiota of milk from mothers with preterm infants

The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…

IBS DAYS 2024 in Bologna with experts from all over the world 

Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.

How gut bacteria can help relieve constipation

A recent study indicates that the abfA cluster might be used as therapeutic target for constipation in humans.

In Crohn’s disease model, a fiber-free diet inhibits colitis by regulating gut bacteria

The findings of a recent study may inform new approaches to treat Crohn’s disease by targeting disease-causing microbes in the gut.

Gut fungi may be linked to inflammation in severe COVID

The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.

‘Hidden’ bacteria could explain recurrent urinary tract infections

The findings of a recent study indicate that effective treatments for recurrent UTIs may require the ability to penetrate human tissues.

Don’t miss the 10th International Human Microbiome Consortium (IHMC) Congress 2024

Alessio Fasano gives an overview of the IHMC Congress to be held in Rome, 22-25 June.

Unraveling disease-specific patterns: loss of microbial cross-feeding in the human gut

Focusing on restoring microbial cross-feeding interactions emerges as a promising mechanism-informed strategy to reconstruct a healthy gut ecosystem.

Immune responses to gut microbes may indicate who benefits from diabetes therapy

The findings of a recent study indicate that antibodies to gut microbes could help identify who may benefit from teplizumab.

Some gut microbes are linked to negative clinical outcomes in people with HIV

The findings of a recent study suggest that the conversion of dietary fiber or lactate to SCFAs influences comorbidity risk associated with HIV.

Fecal microbiota transplants may help fight ‘superbugs’

The findings of a recent study suggest that fecal microbiota transplants reduce colonization with multidrug-resistant organisms in people who received kidney transplants.

Antibiotics alter the gut microbiota in ways that disrupt responses to immunotherapy

The findings of a recent study suggest that antibiotics should be prescribed with caution in cancer patients who are planning to receive PD-1 inhibitors.

Lung bacteria may be associated with brain conditions after severe pneumonia

By suggesting that the bacteria detected in the brain after severe pneumonia originate from the lungs, the findings shed light onto the mechanisms of pneumonia-induced neurological conditions.

Skin microbes may influence the outcome of leishmaniasis

The findings of a recent study may inform new therapies to modulate the skin microbiota in people with leishmaniasis.

The gut microbiota is linked to bloodstream infection in critically ill patients

The findings of a recent study link the gut microbiota and the microorganisms responsible for bloodstream infection in critically ill patients.

Microbiota signature may predict severe outcome of SARS-CoV-2 infection

The findings of a recent study suggest that, during SARS-CoV-2 infection, some bacteria in the upper airways’ microbiota may be associated with a person’s disease progression to intubation.

Commensal microbes modulate skin immunity against bacteria causing Lyme disease

The findings of a recent stydy suggest that the skin microbiota triggers a rapid immune response of resident skin cells at the onset of Borrelia infection.

Mice study hints at how gut microbes may protect from childhood obesity

The findings of a recent study suggest that the microbiota-derived metabolite phenyllactic acid can prevent antibiotic-associated obesity in early life.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top